A case of Sézary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llac124
Abstract: The risk of developing malignancies including cutaneous T-cell lymphoma with use of Janus kinase inhibitors is of concern. Here, we describe a case of Sézary syndrome in a patient during treatment with baricitinib for seronegative… read more here.
Keywords: baricitinib seronegative; zary syndrome; syndrome patient; treatment baricitinib ... See more keywords
Characteristics of patients initiating treatment with baricitinib and outcomes at follow-up: analysis of BSRBR-RA Registry data.
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead074
Abstract: OBJECTIVES To describe selected baseline characteristics, continuation with baricitinib and disease activity over time in patients initiating treatment with baricitinib in a UK real-world rheumatology setting. METHODS Baseline and follow-up data were analysed from baricitinib-treated… read more here.
Keywords: patients initiating; rheumatology; initiating treatment; baricitinib ... See more keywords